ORCID "0000-0001-9636-4113" Bildiri Koleksiyonu için listeleme
-
Rituximab-vemurafenib combination for the treatment of relapsed/Refractory hairy cell leukemia
Sevindik, Ömür; Gemici, Aliihsan; Mutlu, Yaşa Gül; Balık Aydın, Berrin; Çakır, Aslı (CIG Media Group, 2020)Objective: The management of R/R-HCL is not standardized yet. Patients with HCL universally harbor BRAF mutations, which makes BRAF inhibitors a potential treatment approach. The effi cacy and safety of the BRAF inhibitor ... -
Successful use of frontline daratumumab lenalidomide and dexamethasone in transplant ineligible frail patients with moderate renal failure at the time of presentation
Sevindik, Ömür Gökmen; Karakuş, Volkan (CIG Media Group, 2022)Introduction: Treatment of the elderly patients who have varying degrees of renal failure at the time of presentation, both due to the underlying plasma cell dyscrasia or the other comorbidities is a true challenge regarding ... -
Successful use of split dose intravenous daratumumab in an overweight multiple myeloma patient after first dose life threatening infusion-related reaction
Aykaş, Fatma; Karakuş, Volkan; Sevindik, Ömür Gökmen (CIG Media Group, 2022)Introduction: There is a paucity of data regarding the best practice to institute iv Daratumumab (D) in morbid obese patients regarding the infusion rate and duration, optimal dosing, and ideal way to cope with the infusion ... -
Turkish acute lymphoblastic leukemia registry, retrospective phase data
Demirkan, Fatih; Çiftçiler, Rafiye; Sevindik, Ömür Gökmen; Tekgündüz, Emre; Erkurt, Mehmet Ali; Vural, Filiz; Turgut, Burhan; Kaynar, Leylagül; Payzin, Kadriye Bahriye; Doğu, Mehmet Hilmi; Karakuş, Volkan; Altuntaş, Fevzi; Büyükaşık, Yahya (The American Society of Hematology, 2019)Background and Aim: Significant developments have occurred in clinical management of acute lymphoblastic leukemia (ALL) in adults over recent decades. However, treatment results are still not satisfactory especially in ...